Cargando…
CAR-T免疫疗法与非小细胞肺癌：瓶颈与曙光
With the deeper understanding of the pathophysiology and pathogenesis of non-small cell lung cancer (NSCLC) which threatens human health, NSCLC treatment has entered a new era. Transition from traditional treatment based on surgery, radiotherapy and chemotherapy to individualized and precise targete...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583876/ https://www.ncbi.nlm.nih.gov/pubmed/32810975 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.103.10 |